Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026

Novavax (Nasdaq: NVAX) will release its second quarter 2026 financial results before U.S. market open on Thursday, August 6, 2026, and will host a webcast and conference call at 8:30 a.m. ET to discuss financial results and operational highlights.

Rhea-AI Summary

Novavax (Nasdaq: NVAX) will release its second quarter 2026 financial results before U.S. market open on Thursday, August 6, 2026, and will host a webcast and conference call at 8:30 a.m. ET to discuss financial results and operational highlights.

Investors can join via live webcast at ir.novavax.com/events or by phone using U.S. dial-in (+1) 888-880-3330 or international dial-in (+1) 646-357-8766. A replay will be available online and by phone at (+1) 800-770-2030 (U.S.) or (+1) 609-800-9909 (international) with passcode 9097916# starting about two hours after the event.

Argus Jul 30 session 1 alert

+1.36% close to close 0.9x rel. volume Open Argus

Details

News Market Reaction – NVAX

$1.20B Mkt Cap at Peak Alert

On Jul 30, the day this news came out, NVAX closed 1.36% above the previous close.

Data tracked by StockTitan Argus for the Jul 30 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

GAITHERSBURG, Md., July 30, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that the Company plans to release its second quarter 2026 financial results before the open of the U.S. financial markets on Thursday, August 6, 2026. Following the release, Company management will host a webcast and conference call at 8:30 a.m. Eastern Time (ET) to discuss financial results and operational highlights.

Conference call details:
Date:	August 6, 2026
Time:	8:30 a.m. ET
URL to register phone:	Register Here
Dial-in number:	(+1) 888-880-3330 (U.S.) or (+1) 646-357-8766 (International)
Webcast:	The live webcast can be accessed at ir.novavax.com/events

• Participants can join the conference call without operator assistance by registering and entering their phone number with the above URL to receive an instant automated call back.
• Participants can also dial direct to be entered into the call by an operator and will be prompted to request to join the Novavax, Inc. call.
• To ensure a timely connection, it is recommended that participants join at least 10 minutes prior to the scheduled start time.

A replay of the webcast will be available at ir.novavax.com/events and over the phone approximately two hours after the event:

Replay dial-in number:	(+1) 800-770-2030 (U.S.) or (+1) 609-800-9909 (International)
Passcode:	9097916#

About Novavax
Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including its Matrix-M^® adjuvant and protein-based nanoparticles. The Company's corporate growth strategy is designed to deliver value via three key strategic pillars: partnering its technology, capital-efficient research and development (R&D) innovation and a lean and efficient operating model. This includes maximizing impact through partnerships for its marketed products (Nuvaxovid™, R21/Matrix-M™), Matrix technology and R&D assets. Please visit novavax.com and LinkedIn for more information. 

Contacts:

Investors
Naina Zaman 
844-668-2829 
ir@novavax.com 

Media 
Yvonne Sprow 
844-264-8571 
media@novavax.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026-302838333.html

SOURCE Novavax, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Novavax (NVAX) report its Q2 2026 earnings?

Novavax plans to report its second quarter 2026 financial results on Thursday, August 6, 2026, before the U.S. market open. According to Novavax, the release will be followed by a webcast and conference call at 8:30 a.m. ET the same day.

What time is the Novavax (NVAX) Q2 2026 earnings conference call on August 6, 2026?

The Novavax Q2 2026 earnings conference call is scheduled for 8:30 a.m. Eastern Time on August 6, 2026. According to Novavax, management will discuss financial results and operational highlights during the webcast and call following the earnings release.

How can investors access the Novavax (NVAX) Q2 2026 earnings webcast?

Investors can access the Novavax Q2 2026 earnings webcast at ir.novavax.com/events. According to Novavax, participants may also register via the provided URL for an automated callback or join by dialing the listed U.S. or international numbers at the scheduled time.

What are the dial-in numbers for the Novavax (NVAX) Q2 2026 earnings call?

For the Q2 2026 earnings call, U.S. participants can dial (+1) 888-880-3330, and international participants can dial (+1) 646-357-8766. According to Novavax, callers should request to join the Novavax call and connect about 10 minutes early.

Will there be a replay of the Novavax (NVAX) Q2 2026 earnings webcast?

Yes, a replay will be available at ir.novavax.com/events and by phone about two hours after the event. According to Novavax, replay dial-ins are (+1) 800-770-2030 (U.S.) and (+1) 609-800-9909 (international), with passcode 9097916#.

How do I register for the Novavax (NVAX) Q2 2026 earnings call automated callback?

Participants can register online using the provided URL to receive an instant automated callback for the Q2 2026 call. According to Novavax, registration allows joining without operator assistance by entering a phone number to be called at the event time.